buy nero 10 platinum price of ms visio 2010 buy ecotect analysis buy ms powerpoint 2010 buy office powerpoint buy windows 7 cheap student buy adobe photoshop elements 6.0 mac purchase excel 2010 cheap frontpage 2003 buy photoshop elements 6.0 best buy quicken deluxe 2008 solidworks software price buy acrobat 6.0 order windows xp home edition buying used rosetta stone spanish photoshop license expired ms word 2003 buy buy autocad 2011 mac buy office 2003 cheap buying microsoft office 2010 key buy office 2003 student buy aperture 2.0 price of office 2010 for students buy act 2011 buy mappoint 2010 fleet edition buy adobe cs4 master collection mac os x best price filemaker mac office 2007 discount for students buying windows xp home product key buy word for macintosh

Tag Archive | "human papillomavirus"

Salivary gland cancers rare, but sometimes deadly

Saturday, July 12, 2014

0 Comments

Source: articles.baltimoresun.com Author: Andrea K. Walker Professional baseball great Tony Gwynn Sr., also known as Mr. Padre, died last month of salivary gland cancer, which he believed was caused by years of using smokeless chewing tobacco. The cancer is a rare form that begins in any of the salivary glands in the mouth, neck or throat. Two […]

Continue reading...

New immunotherapy drug shows promise for advanced head/neck cancer

Wednesday, June 4, 2014

0 Comments

Source: www.drbicuspid.com Author: DrBicuspid staff A new immunotherapy treatment, MK3475, known as pembrolizumab, from Merck has proved effective in some patients with advanced head and neck, according to the early findings of a study presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. The findings were presented by Tanguy Seiwert, MD, […]

Continue reading...

Low-dose IMRT may be safe for patients with HPV-positive head and neck cancer

Tuesday, June 3, 2014

0 Comments

Source: www.oncologypractice.com Author: Laura Nikolaides Lower-dose radiation therapy may be safe for some patients with human papillomavirus (HPV)-positive oropharyngeal cancer, decreasing the risk of often long-term side effects, such as trouble swallowing, dry mouth, loss of taste, neck stiffness, and thyroid problems, investigators reported at the annual meeting of the American Society of Clinical Oncology. […]

Continue reading...

Cannabinoids may offer hope for patients with oral cancer pain

Thursday, May 15, 2014

0 Comments

Source: www.elements4health.com Even the strongest available pain medications are largely ineffective for many cancer patients, particularly those with oral cancers. One of the nation’s leading oral cancer treating clinicians, speaking at the American Pain Society’s annual meeting, said he believes that while prospects for major treatment advances remain bleak, a new cannabinoid-based medication may have […]

Continue reading...

Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners

Wednesday, April 30, 2014

0 Comments

Authors:  Gypsyamber D’Souza, Neil D. Gross, Sara I. Pai, Robert Haddad, Karen S. Anderson, Shirani Rajan, Jennifer Gerber, Maura L. Gillison, Marshall R. Posner   Source: http://jco.ascopubs.org   Abstract Purpose To better understand oral human papillomavirus (HPV) infection and cancer risk among long-term sexual partners of patients with HPV-positive oropharyngeal cancer (HPV-OPC). Patients and Methods An oral rinse sample, risk factor survey, cancer history, and oral […]

Continue reading...

Beaumont Researchers: biomarkers predict effectiveness of radiation treatments for head and neck cancer

Sunday, March 30, 2014

0 Comments

Source: www.healthcanal.com Author: staff An international team of researchers, led by Beaumont Health System’s Jan Akervall, M.D., Ph.D., looked at biomarkers to determine the effectiveness of radiation treatments for patients with squamous cell cancer of the head and neck. They identified two markers that were good at predicting a patient’s resistance to radiation therapy. Their […]

Continue reading...

Chemoradiation offered better survival than accelerated radiation in head and neck squamous cell carcinomas

Wednesday, March 19, 2014

0 Comments

Source: www.oncologypractice.com Author: Neil Osterweil, Oncology Report Digital Network Concurrent chemoradiation offered better overall survival and disease-free survival than accelerated radiotherapy in patients with moderately advanced squamous cell carcinomas of the head and neck, investigators reported at the Multidisciplinary Head and Neck Symposium. Actuarial rates of 2-year overall survival and disease-free survival in patients treated […]

Continue reading...

Recurrent mouth and throat cancers less deadly when caused by HPV

Wednesday, March 19, 2014

0 Comments

Source: www.oncologynurseadvisor.com Author: Kathy Boltz, PhD People with late-stage cancer at the back of the mouth or throat that recurs after chemotherapy and radiation treatment are twice as likely to be alive 2 years later if their cancer is caused by the human papillomavirus (HPV), suggests new research. This study was presented at the 2014 […]

Continue reading...

Improving QOL in head and neck cancer as survival improves

Friday, February 28, 2014

0 Comments

Source: www.medscape.com Author: Zosia Chustecka In patients undergoing radiation treatment for head and neck cancer, reducing the radiation to organs not affected by cancer is key to improving quality of life post-treatment. Several studies presented here at the 2014 Multidisciplinary Head and Neck Cancer Symposium described new approaches to sparing radiation delivered to the salivary […]

Continue reading...

President’s panel calls for more girls, boys to get HPV vaccine

Tuesday, February 11, 2014

0 Comments

Author: Government news release Source: consumer.healthday.com Too few American girls and boys are getting vaccinated against the cancer-causing human papillomavirus (HPV), the President’s Cancer Panel reported Monday. HPV is linked to cervical cancer as well as penis, rectal and oral cancers. One in four adults in the United States is infected with at least one […]

Continue reading...